cp 96345 has been researched along with Hyperesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuguchi, T; Shimoyama, N; Yamamoto, T | 2 |
2 other study(ies) available for cp 96345 and Hyperesthesia
| Article | Year |
|---|---|
Effects of FK224, a novel cyclopeptide NK1 and NK2 antagonist, and CP-96,345, a nonpeptide NK1 antagonist, on development and maintenance of thermal hyperesthesia evoked by carrageenan injection in the rat paw.
Topics: Animals; Biphenyl Compounds; Carrageenan; Extremities; Hot Temperature; Hyperesthesia; Male; Neurokinin A; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Substance P | 1993 |
The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK1 antagonist, on the hyperesthesia evoked by carageenan injection in the rat paw.
Topics: Animals; Biphenyl Compounds; Carrageenan; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Hyperesthesia; Injections, Spinal; Male; Morphine; N-Methylaspartate; Neurokinin B; Rats; Rats, Sprague-Dawley | 1993 |